Association between genotype and drug resistance profiles of Mycobacterium tuberculosis strains circulating in China in a national drug resistance survey

被引:26
|
作者
Zhou, Yang [1 ]
van den Hof, Susan [2 ,3 ]
Wang, Shengfen [1 ]
Pang, Yu [1 ]
Zhao, Bing [1 ]
Xia, Hui [1 ]
Anthony, Richard [4 ]
Ou, Xichao [1 ]
Li, Qiang [1 ]
Zheng, Yang [1 ]
Song, Yuanyuan [1 ]
Zhao, Yanlin [1 ]
van Soolingen, Dick [4 ]
机构
[1] Chinese Ctr Dis Control & Prevent, Beijing, Peoples R China
[2] KNCV TB Fdn, The Hague, Netherlands
[3] Amsterdam Med Ctr, Dept Global Hlth, Pietersbergweg 17, Amsterdam, Netherlands
[4] Natl Inst Publ Hlth & Environm, Bilthoven, Netherlands
来源
PLOS ONE | 2017年 / 12卷 / 03期
关键词
LARGE SEQUENCE POLYMORPHISMS; GENETIC DIVERSITY; BEIJING GENOTYPE; EVOLUTION; ORIGIN; CLONE; SUBLINEAGES; PULMONARY; RIFAMPIN; INSIGHTS;
D O I
10.1371/journal.pone.0174197
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
We describe the population structure of a representative collection of 3,133 Mycobacterium tuberculosis isolates, collected within the framework of a national resistance survey from 2007 in China. Genotyping data indicate that the epidemic strains in China can be divided into seven major complexes, of which 92% belonged to the East Asian (mainly Beijing strains) or the Euro-American lineage. The epidemic Beijing strains in China are closely related to the Beijing B0/W148 strain earlier described in Russia and a large cluster of these strains has spread national wide. The density of Beijing strains is high in the whole of China (average 70%), but the highest prevalence was found North of the Yellow river. The Euro-American lineage consists of three sublineages (sublineage_1, 2, and 3) and is more prevalent in the South. Beijing lineage showed the highest cluster rate of 48% and a significantly higher level of resistance to rifampicin (14%, p < 0.001), ethambutol (9%, p = 0.001), and ofloxacin (5%, p = 0.011). Within the Euro-American Lineage, sublineage_3 revealed the highest cluster rate (28%) and presented a significantly elevated level of resistance to streptomycin (44%, p < 0.001). Our findings suggest that standardised treatment in this region may have contributed to the successful spread of certain strains: sublineage_3 in the Euro-American lineage may have thrived when streptomycin was used without rifampicin for treatment, while later under DOTS based treatment, in which rifampicin plays a key role, Beijing lineage appears to be spreading.
引用
收藏
页数:13
相关论文
共 50 条
  • [41] Drug Resistance Mechanisms in Mycobacterium tuberculosis
    Palomino, Juan Carlos
    Martin, Anandi
    ANTIBIOTICS-BASEL, 2014, 3 (03): : 317 - 340
  • [42] Mechanisms of drug resistance in Mycobacterium tuberculosis
    Zhang, Y.
    Yew, W. W.
    INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 2009, 13 (11) : 1320 - 1330
  • [43] DRUG RESISTANCE OF MYCOBACTERIUM TUBERCULOSIS IN CHANDIGARH
    MAHAJAN, RC
    AGARWAL, SC
    INDIAN JOURNAL OF MEDICAL RESEARCH, 1968, 56 (08) : 1180 - &
  • [44] Analysis of drug resistance and mutation profiles in Mycobacterium tuberculosis isolates in a surveillance site in Beijing, China
    Zhang, Jie
    Ren, Yixuan
    Pan, Liping
    Yi, Junli
    Guan, Tong
    Yang, Xinyu
    Zhang, Zongde
    JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 2021, 49 (01)
  • [45] A standardised method for interpreting the association between mutations and phenotypic drug resistance in Mycobacterium tuberculosis
    Miotto, Paolo
    Tessema, Belay
    Tagliani, Elisa
    Chindelevitch, Leonid
    Starks, Angela M.
    Emerson, Claudia
    Hanna, Debra
    Kim, Peter S.
    Liwski, Richard
    Zignol, Matteo
    Gilpin, Christopher
    Niemann, Stefan
    Denkinger, Claudia M.
    Fleming, Joy
    Warren, Robin M.
    Crook, Derrick
    Posey, James
    Gagneux, Sebastien
    Hoffner, Sven
    Rodrigues, Camilla
    Comas, Inaki
    Engelthaler, David M.
    Murray, Megan
    Alland, David
    Rigouts, Leen
    Lange, Christoph
    Dheda, Keertan
    Hasan, Rumina
    Ranganathan, Uma Devi K.
    McNerney, Ruth
    Ezewudo, Matthew
    Cirillo, Daniela M.
    Schito, Marco
    Koser, Claudio U.
    Rodwell, Timothy C.
    EUROPEAN RESPIRATORY JOURNAL, 2017, 50 (06)
  • [46] Drug resistance profile of Mycobacterium tuberculosis and predictors associated with the development of drug resistance
    Hameed, Salma
    Ahmad, Sajid Rashid
    Rahman, Mohammad Aqeel ur
    Nazir, Humera
    Ullah, Irfan
    JOURNAL OF GLOBAL ANTIMICROBIAL RESISTANCE, 2019, 18 : 155 - 159
  • [47] Genotypes and drug resistance patterns of multi-drug-resistant mycobacterium tuberculosis strains in Pakistan
    Javed, Hasnain
    Jamil, Nazia
    EUROPEAN RESPIRATORY JOURNAL, 2015, 46
  • [48] Drug resistance and genotypic analysis of Mycobacterium tuberculosis strains from Thai tuberculosis patients
    Cheunoy, Wattana
    Haile, Melles
    Chaiprasert, Angkana
    Prammananan, Therdsak
    Cristea-Fernstrom, Mariana
    Vondracek, Martin
    Chryssanthou, Erja
    Hoffner, Sven
    Petrini, Bjoern
    APMIS, 2009, 117 (04) : 286 - 290
  • [49] Genotype MTBDRplus for Direct Detection of Mycobacterium tuberculosis and Drug Resistance in Strains from Gold Miners in South Africa
    Dorman, Susan E.
    Chihota, Violet N.
    Lewis, James J.
    van der Meulen, Minty
    Mathema, Barun
    Beylis, Natalie
    Fielding, Katherine L.
    Grant, Alison D.
    Churchyard, Gavin J.
    JOURNAL OF CLINICAL MICROBIOLOGY, 2012, 50 (04) : 1189 - 1194
  • [50] Evaluation of the genotype MTBDRs/test for detection of second-line drug resistance in drug-resistant Mycobacterium tuberculosis strains in Myanmar
    Nyunt, Wint Wint
    Aung, Si Thu
    Cook, Gregory M.
    Aung, Htin Lin
    INFECTIOUS DISEASES, 2017, 49 (11-12) : 865 - +